Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 4Unknown 2Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Glioma 1Cognitive Dysfunction 1Cognition Disorders 1Chemotherapy-Related Cognitive Impairment 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Cognitive Training × Clear all
NCT06103318 2024-03-06

ICOgnition

Institut Català d'Oncologia

Phase NA Unknown
176 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT00256425 2008-03-21

Cognitive Rehabilitation of Glioma Patients

UMC Utrecht

Phase 3 Unknown
140 enrolled
CNS

Brain Neoplasms, Cognition Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡